Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

Share Price is delayed by 15 minutes
Get Live Data
32.00    -0.75 (-2.29%)
Bid:
31.00
Ask:
33.00
Spread: 2.00 (6.452%)
Market Cap: £57.87m
IKA Live PriceLast checked at - London Stock Exchange

Intraday Ilika Plc Share Chart

2024 Conference Schedule

15 Jan 2024 07:00

RNS Number : 6021Z
Ilika plc
15 January 2024
 

Ilika plc

("Ilika" or the "Company")

 

 

2024 Conference Schedule

 

Ilika to Attend Major Global Events to Promote Stereax® and Goliath Progress

 

Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces its conference and trade show schedule for the first half of 2024 - with the team attending several major MedTech and Automotive conferences. At each event Ilika representatives will either give a presentation, chair a session, form part of a panel or be available at a booth, enabling thought-leadership exchange and engagement with key industry peers and prospective business partners.

 

Ilika will use the MedTech conferences to further promote its developing relationship with Cirtec Medical and to provide updates on its ten-year manufacturing licence to produce the Stereax range of mm-scale batteries at Cirtec's facility. The Company will use its attendance at Automotive conferences to raise the profile of its programme to manufacture and test batches of Goliath pouch cells as development continues to target delivery of fully characterised cells to its customers.

 

Medical Devices Conferences

 

North American Neuromodulation Society (NANS) Annual Meeting

For the first time, Ilika and Cirtec Medical will be sharing a booth (#505) to jointly promote Stereax miniature solid state batteries at the 2024 NANS Annual Meeting, on January 18-21 in Las Vegas, USA.

 

Medical Device and Manufacturing (MD&M) West

MD&M will be held on February 6-8 in Anaheim, USA where Ilika will give a presentation to the Medical Battery Conference section of the show, discussing the potential benefits Stereax solid state batteries can deliver in miniaturisation and active implanted medical devices.

 

Automotive and Electric Vehicle Conferences

 

International Battery Seminar (IBS)

At IBS, March 12-15 in Orlando, USA, Ilika's Product Manager, Dr Denis Pasero, will chair the "Solid State Battery Program Update" session.

 

Battery Tech Expo

At Battery Tech Expo, April 25 in Silverstone, UK, Ilika will provide an update on its progress developing the first Goliath solid state battery product and its activity securing the scale-up of its technology.

 

MOVE 2024

CEO Graeme Purdy will join a panel to discuss solid state batteries for transportation at MOVE 2024, on June 19-20 in London. Ilika will use the event to network and identify trends emerging from other prestigious shows in the calendar.

 

Graeme Purdy, Ilika CEO stated: "This is an exciting year for Ilika with both our Goliath and Stereax solid state batteries moving forward in line with our roadmap. Last year, we finalised our partnership with Cirtec Medical to manufacture and commercialise our Stereax mm-scale batteries, and we achieved our D4 development point and lithium-ion energy density parity with our Goliath technology for electric vehicles. As we continue with our roadmap this year, we'll be presenting updates at key worldwide events, showing how our technology can transform both the EV and the MedTech markets."

 

For more information contact:

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive Officer

Via Walbrook PR

Jason Stewart, Chief Financial Officer

Liberum Capital Limited (Nomad and Joint Broker)

Tel: 020 3100 2000

Andrew Godber,

Nikhil Varghese

Joh. Berenberg, Gossler & Co. KG (Joint Broker)

Tel: 020 3207 8700

Matthew Armitt, Mark Whitmore, Detlir Elezi,

Mara Grasso

Walbrook PR Ltd

Tel: 020 7933 8780 / Ilika@walbrookpr.com

Nick Rome, Charlotte Edgar, Joe Walker

 

About Ilika plc - https://www.ilika.com

Ilika specialises in the developing and commercialisation of solid state batteries. The Company's mission is to rapidly develop leading-edge IP, manufacture and license solid state batteries for markets that cannot be addressed with conventional batteries due to their safety, charge rates, energy density and life limits. The Company achieves this by using ceramic-based lithium-ion technology that is inherently safe in manufacture and usage, higher thermal tolerance and easier to recycle which differentiates our products from existing batteries.

 

The Company has two product lines. Its Stereax batteries which are designed for powering miniature medical implants, industrial wireless sensors and specialist internet of Things (IoT) applications and the Goliath large format batteries designed for EV cars and cordless appliances.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASFDFWEELSEEF
Date   Source Headline
21st May 20267:00 amRNSIlika Trading Update and Notice of Results
10th Apr 20264:01 pmRNSCollaboration with Brompton Bicycles
18th Mar 20267:00 amRNSPositive Feedback on Safety of Goliath Cells
10th Mar 20267:00 amRNSFirst Commercial Delivery to Cirtec Medical
24th Feb 202610:21 amRNSAward of Share Options
19th Feb 20267:00 amRNS-RIlika at Yellowstone Investor Evening: Replacement
22nd Jan 20267:00 amRNSHalf-year Financial Report
21st Jan 20267:00 amRNSIlika Secures Stereax Electrode Order from Cirtec
18th Dec 20257:00 amRNSInitial Stereax M300 Shipments
11th Dec 20257:00 amRNSIlika Ships 10Ah Goliath Battery Prototypes
20th Nov 20257:00 amRNSTrading Update & Notice of Half-Year Results
21st Oct 20257:00 amRNSCommissioning Complete for Goliath Pilot Line
1st Oct 202512:00 pmRNSExercise of Options and Total Voting Rights
23rd Sep 20253:43 pmRNSResult of AGM & Award of Executive Share Options
22nd Sep 20257:00 amRNSStart of Primed Solid-State Battery Programme
28th Aug 20257:00 amRNSNotice of AGM and Posting of Annual Report
18th Aug 20257:00 amRNSStereax Battery Milestone at Cirtec Medical
17th Jul 20258:56 amRNSHolding(s) in Company
17th Jul 20257:00 amRNSFinal Results
15th Jul 20257:00 amRNSAward of Government Grant Funding
11th Jun 20252:09 pmRNSNotice of Results
4th Jun 20252:14 pmRNSHolding(s) in Company
3rd Jun 20251:57 pmRNSHolding(s) in Company
28th May 20256:00 pmRNSResult of Oversubscribed Retail Offer
22nd May 20252:16 pmRNSRetail Offer for up to £0.5 million
22nd May 20251:53 pmRNSResult of Placing & Director Subscription
21st May 20255:14 pmRNSProposed Capital Raise
7th May 202510:03 amRNS-RIlika announces 2025 Investor Day
1st May 20257:00 amRNSGoliath P1 Cells Validated by Customer Testing
15th Apr 20257:00 amRNSGoliath Battery Achieves Scale-up Milestone
6th Mar 20257:00 amRNSGoliath Development Progress
27th Feb 20257:00 amRNSAward & Exercise of Share Options
6th Feb 20253:49 pmRNSHolding(s) in Company
5th Feb 20257:00 amRNSGoliath Scale-up Progress
21st Jan 20257:00 amRNSHalf-year Results
9th Jan 20257:00 amRNSStereax Equipment Commissioning Completed
19th Dec 20247:00 amRNSAppointment of Nominated Adviser and Sole Broker
22nd Nov 20242:18 pmRNSAIM Rule 17 Schedule 2(g) Update
20th Nov 20247:00 amRNSGoliath D6 milestone reached
15th Nov 20247:00 amRNSTrading Update & Notice of Half-Year Results
10th Oct 20241:49 pmRNSHolding(s) in Company
3rd Oct 20247:00 amRNSFurther Goliath Technical Milestone Achieved
29th Aug 20247:00 amRNSPosting of Annual Report and Notice of AGM
11th Jul 20247:00 amRNSFinal Results
2nd Jul 20247:00 amRNSKey Technology Validation Milestone
1st Jul 20247:00 amRNSNominated Adviser and Joint Broker
31st May 20242:29 pmRNSHolding(s) in Company
29th May 202411:52 amRNSResults of General Meeting Open Offer and TVR
22nd May 20247:00 amRNSKey Goliath Technology Validation Milestone
16th May 20247:00 amRNSTrading Update, Notice of Results & Presentations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.